Particella
PrivateLast Round
Grant
Nov 13, 2024
Total Funding Raised
$9.14M
Company Overview
Particella is a biotechnology company that develops oral lipid nanoparticle technology to deliver nucleic acids to the intestinal epithelium.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Particella Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Particella Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 13, 2024 | ||||
| Series A | Apr 1, 2022 | ||||
| Grant | Oct 5, 2020 | ||||
| Seed | Aug 8, 2018 | ||||
| Accelerator | May 31, 2017 |
Particella Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blue Bear Ventures | Seed |
| Gates Foundation | Grant |
| Berkeley Catalyst Fund | Seed |
| IndieBio | Accelerator |
| Baldota Family Office | Seed |
| SVE Capital | Seed |
| SOSV | Series A, Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2022
Raised $5.6M from Mayfield Fund and SOSV
- Oct 5, 2020
$290K grant from the Gates Foundation
Particella Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Particella's valuation, stock price, and market status.